Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on LATAM News Online.
Press releases published on August 5, 2025
Ideon Raises the Bar with ‘Smarter’ Subsurface Beacon
EIN Presswire
·
August 5, 2025
Ultra-reliable, multi-modal, long-life solution supercharges REVEAL™ for Caving solution VANCOUVER, BRITISH COLUMBIA, CANADA, August 4, 2025 /EINPresswire.com/ -- Canadian subsurface intelligence leader Ideon Technologies is bringing a new, ‘smarter’, …
Treat yourself to La Paz, BCS. The ultimate gastronomy options - and more - for a delicious trip at the end of this summer
GlobeNewswire
·
August 5, 2025
La Paz, Baja California Sur, Aug. 05, 2025 (GLOBE NEWSWIRE) -- Brimming with flavours, textures, aromas, and colours, the gastronomy of La Paz, B.C.S. has its own identity—a distinct mix of sea and desert traditions, and a place where many chefs have …
Pan American Energy Reports Assay Results from Winter Drilling at Big Mack Project
GlobeNewswire
·
August 5, 2025
CALGARY, Alberta, Aug. 05, 2025 (GLOBE NEWSWIRE) -- Pan American Energy Corp. (the “Company” or “Pan American”) (CSE: PNRG) (OTC PINK: PAANF) (FRA: SS6) is pleased to report assay results from its Winter 2024 diamond drilling program at the Big Mack …
Silo Pharma Appoints Crypto Infrastructure Pioneer Corwin Yu to Launch Institutional Bitcoin, Ethereum and Solana Treasury Platform
GlobeNewswire
·
August 5, 2025
Targeting Multi-Chain Digital Asset Growth and Decentralized Finance (DeFi) Integration SARASOTA, FL, Aug. 05, 2025 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (Nasdaq: SILO), today announced the launch of a cryptocurrency treasury strategy which is expected to …
Soligenix Inc. (NASDAQ: SNGX) Innovative Platform Provides Novel Treatment for Underserved CTCL Space
GlobeNewswire
·
August 5, 2025
NEW YORK, Aug. 05, 2025 (GLOBE NEWSWIRE) -- via InvestorWire — Soligenix Inc. (NASDAQ: SNGX) today announces its placement in an editorial published by NetworkNewsWire ("NNW"), one of 70+ brands within the Dynamic Brand Portfolio@IBN (InvestorBrandNetwork …
Veru to Report Fiscal 2025 Third Quarter Financial Results on August 12th
GlobeNewswire
·
August 5, 2025
MIAMI, Aug. 05, 2025 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on developing innovative medicines for the treatment of cardiometabolic and inflammatory diseases, today announced it will host a …
Clene to Present at the Canaccord 45th Annual Growth Conference
GlobeNewswire
·
August 5, 2025
SALT LAKE CITY, Aug. 05, 2025 (GLOBE NEWSWIRE) -- Clene Inc. (Nasdaq: CLNN) (along with its subsidiaries, “Clene”) and its wholly owned subsidiary Clene Nanomedicine Inc., a late clinical-stage biopharmaceutical company focused on revolutionizing the …
Assertio Holdings, Inc. to Report Second Quarter 2025 Financial Results on August 11, 2025
GlobeNewswire
·
August 5, 2025
LAKE FOREST, Ill., Aug. 05, 2025 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT) today announced that it will release second quarter 2025 financial results on Monday, August 11, 2025, after the market close. …
SERB Pharmaceuticals Agrees to Acquire Y-mAbs Therapeutics
GlobeNewswire
·
August 5, 2025
Acquisition to Include Naxitamab-gqgk DANYELZA® (Naxitamab-gqgk), Further Broadening SERB’s Rare Oncology Product Portfolio Transaction Expands SERB’s Investment in the U.S. SERB to Commence All-Cash Tender Offer to Acquire All Outstanding Shares of Y-mAbs …
Clearmind Medicine Receives IRB Approval for Phase 1/2a Clinical Trial for Alcohol Use Disorder at Hadassah Medical Center
GlobeNewswire
·
August 5, 2025
IRB Approval from Hadassah Medical Center Follows FDA IND Clearance and Prior Approvals from Additional Clinical Sites Vancouver, Canada, Aug. 05, 2025 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), …
CHO Plus Enters into Project Agreement with BARDA’s BioMaP Consortium to Develop High Productivity Cell Lines for Filovirus Monoclonal Antibody Production
GlobeNewswire
·
August 5, 2025
SOUTH SAN FRANCISCO, Calif., Aug. 05, 2025 (GLOBE NEWSWIRE) -- Privately held CHO Plus, Inc. announced today a project agreement awarded from the Biomedical Advanced Research and Development Authority’s (BARDA) Biopharmaceutical Manufacturing Preparedness …
Entrée Resources Provides Corporate Update
GlobeNewswire
·
August 5, 2025
VANCOUVER, British Columbia, Aug. 05, 2025 (GLOBE NEWSWIRE) -- Entrée Resources Ltd. (TSX:ETG; OTCQB:ERLFF – the “Company” or “Entrée”) provides an update regarding efforts to transfer the Shivee Tolgoi and Javkhlant mining licenses (the “JV Licenses”) in …
Vortex Energy Mobilizes Field Crews for ANT Survey at Robinsons River Salt Project
GlobeNewswire
·
August 5, 2025
VANCOUVER, British Columbia, Aug. 05, 2025 (GLOBE NEWSWIRE) -- Vortex Energy Corp. (CSE: VRTX) (OTC: VTECF) (FSE: AA3) (“Vortex” or the “Company”) is pleased to announce that field crews are mobilizing to the Robinsons River Salt Project in Newfoundland to …
ALX Oncology to Report Second Quarter 2025 Financial Results on August 12, 2025
GlobeNewswire
·
August 5, 2025
SOUTH SAN FRANCISCO, Calif., Aug. 05, 2025 (GLOBE NEWSWIRE) -- ALX Oncology Holdings Inc., ("ALX Oncology" or the "Company") (Nasdaq: ALXO), a clinical-stage biotechnology company advancing a pipeline of novel therapies designed to treat cancer and extend …
UroGen Announces 24-Month Duration of Response of 72.2% from the Pivotal Phase 3 ENVISION Trial of ZUSDURI, the First and Only FDA-Approved Medicine for Recurrent Low-Grade Intermediate-Risk Non-Muscle Invasive Bladder Cancer
GlobeNewswire
·
August 5, 2025
24-month Duration of Response (DOR) of 72.2% by Kaplan-Meier estimate was attained in patients who achieved a complete response (CR) at three months (79.6%) PRINCETON, N.J., Aug. 05, 2025 (GLOBE NEWSWIRE) -- UroGen Pharma Ltd. (Nasdaq: URGN), a biotech …
Cogent Biosciences Reports Recent Business Highlights and Second Quarter 2025 Financial Results
GlobeNewswire
·
August 5, 2025
Reported positive top-line results from SUMMIT evaluating bezuclastinib in patients with NonAdvanced Systemic Mastocytosis, achieving statistical significance across all primary and key secondary endpoints On track to share pivotal trial results from PEAK …
GDEV acquires Light Hour Games to expand its portfolio in mobile casual games
GlobeNewswire
·
August 5, 2025
LIMASSOL, Cyprus, Aug. 05, 2025 (GLOBE NEWSWIRE) -- GDEV Inc. (Nasdaq: GDEV), a global gaming and entertainment company, today announced the acquisition of Light Hour Games, a privately held mobile studio based in Cyprus. Light Hour Games is a full-stack …
Cocrystal Pharma Presents Phase 1 Results for Pan-Viral Inhibitor CDI-988 at Department of Defense Medical Conference
GlobeNewswire
·
August 5, 2025
All CDI-988 doses, ranging from 100 mg to 1200 mg, in the Phase 1 study were well tolerated Company expects to initiate Phase 1b study with CDI-988 in norovirus-infected healthy subjects later this year Lack of approved norovirus treatments or vaccines …
LYNO AI Reports Early Engagement in Presale with Over 100,000 Tokens Acquired
GlobeNewswire
·
August 5, 2025
ROAD TOWN, British Virgin Islands, Aug. 05, 2025 (GLOBE NEWSWIRE) -- LYNO AI, a decentralized protocol leveraging machine learning for cross-chain arbitrage trading, has announced a strong start to its presale campaign. During the Early Bird phase, a total …
American Tungsten Strengthens Leadership Team to Drive Mining Operations Expansion
GlobeNewswire
·
August 5, 2025
Vancouver, BC, Aug. 05, 2025 (GLOBE NEWSWIRE) -- American Tungsten Corp. (CSE:TUNG) (OTCQB:DEMRF) (FSE:RK9) (“American Tungsten” or the “Company”) is pleased to announce the appointment of David Sabourin (PE, MBA) as Vice President of Mining Operations and …